Gresele, Paolo
Guglielmini, Giuseppe
Del Pinto, Maurizio
CalabrĂ², Paolo
Pignatelli, Pasquale
Patti, Giuseppe
Pengo, Vittorio
Antonucci, Emilia
Cirillo, Plinio
Fierro, Tiziana
Palareti, Gualtiero
Marcucci, Rossella
,
Riccini, C.
Cesaro, A.
Gragnano, F.
Menichelli, D.
Pastori, D.
Cavallari, I.
Denas, G.
Zoppellaro, G.
Di Serafino, L.
De Rosa, G.
Grossi, G.
Piazzai, C.
Article History
Received: 22 December 2023
Accepted: 5 June 2024
First Online: 24 June 2024
Competing interests
: P. Gresele declares to be speaker, consultant, member of advisory board for Roche, Sanofi, Viatris, Werfen, STAGO, Kedrion. G. Patti declares to be speaker, consultant, member of advisory board for Amgen, Sanofi, Bayer, Bohering-Ingelheim, BMS-Pfizer, Daiichi Sanyo, Astra Zeneca, Sigma-Tau, Malesci, PIAM and MDS. R. Marcucci declares to be speaker, consultant, member of advisory board for Sanofi, Novartis, Bayer, Amgen, Werfen, Astra Zeneca, Servier. All the other authors declare no conflict of interest.